Mimi M. Hou

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Development of clinical immunity to Plasmodium vivax following repeat controlled human malaria infection.

Development of clinical immunity to Plasmodium vivax following repeat controlled human malaria infection.

Journal: Nature communications

Published: June 20, 2025

Higher HIV-1 evolutionary rate is associated with cytotoxic T lymphocyte escape mutations in infants.

Higher HIV-1 evolutionary rate is associated with cytotoxic T lymphocyte escape mutations in infants.

Journal: Journal of virology

Published: May 30, 2024

Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial.

Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial.

Journal: The Lancet. Infectious diseases

Published: March 25, 2024

Evaluation of the precision of the Plasmodium knowlesi growth inhibition assay for Plasmodium vivax Duffy-binding protein-based malaria vaccine development.

Evaluation of the precision of the Plasmodium knowlesi growth inhibition assay for Plasmodium vivax Duffy-binding protein-based malaria vaccine development.

Journal: Vaccine

Published: March 01, 2024

PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial.

PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial.

Journal: NPJ vaccines

Published: August 17, 2023

Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection.

Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection.

Journal: Science translational medicine

Published: July 12, 2023

Analyses of human vaccine-specific circulating and bone marrow-resident B cell populations reveal benefit of delayed vaccine booster dosing with blood-stage malaria antigens.

Analyses of human vaccine-specific circulating and bone marrow-resident B cell populations reveal benefit of delayed vaccine booster dosing with blood-stage malaria antigens.

Journal: Frontiers in immunology

Published: March 24, 2023

Repeat controlled human malaria infection of healthy UK adults with blood-stage Plasmodium falciparum: Safety and parasite growth dynamics.

Repeat controlled human malaria infection of healthy UK adults with blood-stage Plasmodium falciparum: Safety and parasite growth dynamics.

Journal: Frontiers in immunology

Published: July 01, 2022

Impact of a blood-stage vaccine on Plasmodium vivax malaria.

Impact of a blood-stage vaccine on Plasmodium vivax malaria.

Journal: medRxiv : the preprint server for health sciences

Published: June 06, 2022

Controlled human malaria infection with a clone of Plasmodium vivax with high-quality genome assembly.

Controlled human malaria infection with a clone of Plasmodium vivax with high-quality genome assembly.

Journal: JCI insight

Published: October 05, 2021

Fatal tuberculous meningitis in an infant presenting with seizures in the UK.

Fatal tuberculous meningitis in an infant presenting with seizures in the UK.

Journal: BMJ case reports

Published: August 20, 2021

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.

Journal: Lancet (London, England)

Published: October 30, 2020

Showing 1-12 of 12

Last Updated: 09/26/2026